iRadimed Corporation (IRMD) Stock Price

IRMDStock

$88.27+16.07%52W

Market Cap$1.13B

P/E50.21x

PEG Ratio0.67

Div yield0.87%

Beta0.94

IRMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-15.56%

Price vs S&P 500 (4W)8.37%

PEG Ratio0.67

VGM Score51.05

P/E Ratio (Annual)50.21x

Indicated Dividend Yield (Annual)0.87%

P/CF (Annual)45.24x

Book Value / Share (Quarterly)$7.96

P/TBV (Annual)13.56x

Indicated Dividend (Annual)$0.80

Revenue Growth (3Y)16.29%

Cash Flow / Share (Quarterly)$1.92

Payout Ratio (TTM)68.66%

Price vs S&P 500 (YTD)-21.19%

Gross Margin (TTM)75.86%

Net Profit Margin (TTM)26.70%

EPS (TTM)$1.79

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$1.79

Revenue Growth (5Y)21.45%

EPS (Annual)$1.75

Dividend / Share (Annual)$1.18

ROI (Annual)23.76%

Gross Margin (Annual)76.75%

Net Profit Margin (5Y Avg)25.14%

Cash / Share (Quarterly)$4.62

P/E Basic Excl Extra (TTM)48.96x

Revenue Growth QoQ (YoY)0.28%

EPS Growth (5Y)73.86%

P/E Normalized (Annual)50.21x

ROA (Last FY)20.67%

Revenue Growth TTM (YoY)11.21%

EBITD / Share (TTM)$2.27

ROE (5Y Avg)20.07%

Operating Margin (TTM)31.92%

Cash Flow / Share (Annual)$1.29

P/B Ratio11.09x

P/B Ratio (Quarterly)12.01x

Net Income / Employee (Annual)$135,400

EV / Revenue (TTM)12.39x

Net Interest Coverage (TTM)1096.00x

ROA (TTM)20.36%

EPS Growth QoQ (YoY)-9.87%

EV / EBITDA (TTM)36.65x

EPS Incl Extra (Annual)$1.75

Current Ratio (Annual)7.98x

Quick Ratio (Quarterly)7.89x

3-Month Avg Trading Volume0.13M

52-Week Price Return16.07%

EV / Free Cash Flow (Annual)64.72x

P/E Incl Extra (TTM)48.96x

Revenue / Employee (TTM)$520,100

Tangible BV / Share (Quarterly)$7.69

P/S Ratio (Annual)13.47x

Asset Turnover (Annual)0.77x

52-Week High$107.90

Operating Margin (5Y Avg)28.91%

EPS Excl Extra (Annual)$1.75

CapEx CAGR (5Y)67.43%

Tangible BV CAGR (5Y)8.59%

26-Week Price Return-5.65%

Quick Ratio (Annual)6.37x

13-Week Price Return-9.03%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.46x

Enterprise Value$1.07B

Revenue / Share Growth (5Y)20.66%

Asset Turnover (TTM)0.76x

Book Value / Share Growth (5Y)8.22%

Revenue / Employee (Annual)$504,900

Inventory Turnover (Annual)1.77x

Pretax Margin (Annual)33.84%

Cash / Share (Annual)$4.00

3-Month Return Std Dev21.71%

Gross Margin (5Y Avg)76.86%

Net Income / Employee (TTM)$138,900

EBITDA CAGR (5Y)116.07%

EBITDA Interim CAGR (5Y)25.44%

ROE (Last FY)23.76%

EPS Basic Excl Extra (Annual)$1.75

P/FCF (TTM)45.98x

Receivables Turnover (TTM)7.16x

EV / Free Cash Flow (TTM)43.58x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$1.79

Receivables Turnover (Annual)6.92x

ROI (TTM)23.45%

P/S Ratio (TTM)13.07x

Pretax Margin (5Y Avg)30.81%

Revenue / Share (Annual)$6.52

Tangible BV / Share (Annual)$7.14

Forward P/E38.40x

Free OCF CAGR (5Y)26.12%

Price vs S&P 500 (52W)0.54%

P/E Ratio (TTM)48.96x

EPS Growth TTM (YoY)11.16%

Year-to-Date Return-9.26%

5-Day Price Return-1.34%

EPS Normalized (Annual)$1.75

ROA (5Y Avg)17.03%

Net Profit Margin (Annual)26.82%

Month-to-Date Return2.38%

Cash Flow / Share (TTM)$1.34

EBITD / Share (Annual)$2.12

EPS Growth (3Y)19.89%

Operating Margin (Annual)31.20%

P/CF (TTM)41.59x

ROI (5Y Avg)20.07%

P/E Excl Extra (TTM)48.96x

EPS Basic Excl Extra (TTM)$1.79

P/TBV (Quarterly)12.43x

Payout Ratio (Annual)66.90%

P/B Ratio (Annual)13.08x

Dividend / Share (TTM)$1.24

Inventory Turnover (TTM)1.78x

Pretax Margin (TTM)34.45%

Book Value / Share (Annual)$7.40

Price vs S&P 500 (13W)-11.71%

Net Margin Growth (5Y)44.08%

Dividend Yield (TTM)1.40%

Beta0.94x

P/FCF (Annual)68.30x

Revenue / Share (TTM)$6.71

ROE (TTM)23.45%

52-Week Low$73.02

vGradeD

gGradeB

mGradeB

vgmGradeC

IRMD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 31, 2026	$0.44	$0.46	+4.55%(+$0.02)
Q1 2026	May 1, 2026	$0.45	$0.49	+10.11%(+$0.04)
Q4 2025	Feb 10, 2026	$0.48	$0.54	+12.50%(+$0.06)
Q3 2025	Nov 3, 2025	$0.46	$0.47	+3.30%(+$0.01)
Q2 2025	Aug 1, 2025	$0.43	$0.49	+12.64%(+$0.05)

IRMD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About iRadimed Corporation

iRadimed manufactures MRI-compatible medical devices, including non-magnetic IV infusion pump systems and patient vital signs monitors for use during MRI procedures. The company sells to hospitals and acute care facilities in the United States and internationally, with the majority of revenue derived from the U.S. market.

IRMD Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.55

Revenue estimate$23.43M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

IRMD Insider Transactions

SellSep 3, 2026
ALLEN MONTY K
Director
Shares: 1,419Value: $122,622

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

EYENational Vision Holdings, Inc. Common StockOphthalmic Goods
LYNXLyntris Inc.Defense Systems & Equipment
ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$73.02

High$107.90